Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
accidentally reconstituted vaccine with a sterile diluent instead of the lyophilized powder; accidentally reconstituted vaccine with a sterile diluent instead of the lyophilized powder; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: accidentally reconstituted vaccine with a sterile diluent instead of the lyophilized powder) and inappropriate dose of vaccine administered (Verbatim: accidentally reconstituted vaccine with a sterile diluent instead of the lyophilized powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 26-MAR-2025 Other HCP reported that one of their Medical Assistants accidentally reconstituted the Shingrix vaccine with a sterile diluent instead of the lyophilized powder when the 1st dose was administered to a patient. Reporter would like to know if it's still okay to administer the 2 doses of Shingrix to the patient since the initial dose was prepared and administered to the patient incorrectly. What should they do in this situation and is it safe for the patient or not. Reporter asked if there are any additional side effects for the patient they should be aware of. The patient received Shingrix vaccine with a sterile diluent instead of the lyophilized powder of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.